Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Kenilworth, NJ
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Kenilworth, NJ
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Moorestown, NJ
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Moorestown, NJ
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Piscataway, NJ
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Piscataway, NJ
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Princeton, NJ
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Princeton, NJ
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Albany, NY
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Albany, NY
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Lawrence, NY
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Lawrence, NY
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
New York, NY
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Rochester, NY
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Rochester, NY
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Columbus, OH
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Concinnati, OH
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Concinnati, OH
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Lyndhurst, OH
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Lyndhurst, OH
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Toledo, OH
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Toledo, OH
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Eugene, OR
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Eugene, OR
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Portland, OR
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Allentown, PA
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Allentown, PA
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Havertown, PA
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Havertown, PA
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Philadelphia, PA
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Lincoln, RI
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Lincoln, RI
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Woodstock, VT
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Woodstock, VT
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Spokane, WA
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Spokane, WA
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Brown Deer, WI
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Brown Deer, WI
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Madison, WI
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Madison, WI
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Menomonee Falls, WI
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Menomonee Falls, WI
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Middleton, WI
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Middleton, WI
Click here to add this to my saved trials
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users
Status: Enrolling
Updated:  1/11/2017
Midtown Community Mental Health Center
mi
from
Indianapolis, IN
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users
Status: Enrolling
Updated: 1/11/2017
Midtown Community Mental Health Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users
Status: Enrolling
Updated:  1/11/2017
Jefferson Alcohol & Drug Abuse Center
mi
from
Louisville, KY
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users
Status: Enrolling
Updated: 1/11/2017
Jefferson Alcohol & Drug Abuse Center
mi
from
Louisville, KY
Click here to add this to my saved trials
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users
Status: Enrolling
Updated:  1/11/2017
Eleonore Hutzel Recovery Center
mi
from
Detroit, MI
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users
Status: Enrolling
Updated: 1/11/2017
Eleonore Hutzel Recovery Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users
Status: Enrolling
Updated:  1/11/2017
Milagro Clinic
mi
from
Albuquerque, NM
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users
Status: Enrolling
Updated: 1/11/2017
Milagro Clinic
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users
Status: Enrolling
Updated:  1/11/2017
Milagro
mi
from
Albuquerque, NM
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users
Status: Enrolling
Updated: 1/11/2017
Milagro
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users
Status: Enrolling
Updated:  1/11/2017
Coastal Horizons Center, Inc.
mi
from
Wilmington, NC
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users
Status: Enrolling
Updated: 1/11/2017
Coastal Horizons Center, Inc.
mi
from
Wilmington, NC
Click here to add this to my saved trials
Women's Treatment for Trauma and Substance Use Disorders - 1
Women's Treatment for Trauma and Substance Use Disorders
Status: Enrolling
Updated:  1/11/2017
Gateway Community Services
mi
from
Jacksonville, FL
Women's Treatment for Trauma and Substance Use Disorders - 1
Women's Treatment for Trauma and Substance Use Disorders
Status: Enrolling
Updated: 1/11/2017
Gateway Community Services
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Women's Treatment for Trauma and Substance Use Disorders - 1
Women's Treatment for Trauma and Substance Use Disorders
Status: Enrolling
Updated:  1/11/2017
The Villiage
mi
from
Miami, FL
Women's Treatment for Trauma and Substance Use Disorders - 1
Women's Treatment for Trauma and Substance Use Disorders
Status: Enrolling
Updated: 1/11/2017
The Villiage
mi
from
Miami, FL
Click here to add this to my saved trials
Women's Treatment for Trauma and Substance Use Disorders - 1
Women's Treatment for Trauma and Substance Use Disorders
Status: Enrolling
Updated:  1/11/2017
Addiction Research & Treatment Corp.-MSUCAS
mi
from
Brooklyn, NY
Women's Treatment for Trauma and Substance Use Disorders - 1
Women's Treatment for Trauma and Substance Use Disorders
Status: Enrolling
Updated: 1/11/2017
Addiction Research & Treatment Corp.-MSUCAS
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Women's Treatment for Trauma and Substance Use Disorders - 1
Women's Treatment for Trauma and Substance Use Disorders
Status: Enrolling
Updated:  1/11/2017
Addiction Research & Treatment Corp.-RISE
mi
from
Brooklyn, NY
Women's Treatment for Trauma and Substance Use Disorders - 1
Women's Treatment for Trauma and Substance Use Disorders
Status: Enrolling
Updated: 1/11/2017
Addiction Research & Treatment Corp.-RISE
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Women's Treatment for Trauma and Substance Use Disorders - 1
Women's Treatment for Trauma and Substance Use Disorders
Status: Enrolling
Updated:  1/11/2017
Maryhaven
mi
from
Columbus, OH
Women's Treatment for Trauma and Substance Use Disorders - 1
Women's Treatment for Trauma and Substance Use Disorders
Status: Enrolling
Updated: 1/11/2017
Maryhaven
mi
from
Columbus, OH
Click here to add this to my saved trials
Women's Treatment for Trauma and Substance Use Disorders - 1
Women's Treatment for Trauma and Substance Use Disorders
Status: Enrolling
Updated:  1/11/2017
The Charleston Center
mi
from
Charleston, SC
Women's Treatment for Trauma and Substance Use Disorders - 1
Women's Treatment for Trauma and Substance Use Disorders
Status: Enrolling
Updated: 1/11/2017
The Charleston Center
mi
from
Charleston, SC
Click here to add this to my saved trials
Women's Treatment for Trauma and Substance Use Disorders - 1
Women's Treatment for Trauma and Substance Use Disorders
Status: Enrolling
Updated:  1/11/2017
Residence XII
mi
from
Kirkland, WA
Women's Treatment for Trauma and Substance Use Disorders - 1
Women's Treatment for Trauma and Substance Use Disorders
Status: Enrolling
Updated: 1/11/2017
Residence XII
mi
from
Kirkland, WA
Click here to add this to my saved trials
Motivational Enhancement for Spanish Speaking Individuals - 1
Motivational Enhancement for Spanish Speaking Individuals
Status: Enrolling
Updated:  1/11/2017
Island Grove RTC
mi
from
Greeley, CO
Motivational Enhancement for Spanish Speaking Individuals - 1
Motivational Enhancement for Spanish Speaking Individuals
Status: Enrolling
Updated: 1/11/2017
Island Grove RTC
mi
from
Greeley, CO
Click here to add this to my saved trials
Motivational Enhancement for Spanish Speaking Individuals - 1
Motivational Enhancement for Spanish Speaking Individuals
Status: Enrolling
Updated:  1/11/2017
Miami Behavioral Health
mi
from
Miami, FL
Motivational Enhancement for Spanish Speaking Individuals - 1
Motivational Enhancement for Spanish Speaking Individuals
Status: Enrolling
Updated: 1/11/2017
Miami Behavioral Health
mi
from
Miami, FL
Click here to add this to my saved trials
Motivational Enhancement for Spanish Speaking Individuals - 1
Motivational Enhancement for Spanish Speaking Individuals
Status: Enrolling
Updated:  1/11/2017
Counseling & Psychotherapy Institute
mi
from
Albuquerque, NM
Motivational Enhancement for Spanish Speaking Individuals - 1
Motivational Enhancement for Spanish Speaking Individuals
Status: Enrolling
Updated: 1/11/2017
Counseling & Psychotherapy Institute
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Motivational Enhancement for Spanish Speaking Individuals - 1
Motivational Enhancement for Spanish Speaking Individuals
Status: Enrolling
Updated:  1/11/2017
The Life Link
mi
from
Santa Fe, NM
Motivational Enhancement for Spanish Speaking Individuals - 1
Motivational Enhancement for Spanish Speaking Individuals
Status: Enrolling
Updated: 1/11/2017
The Life Link
mi
from
Santa Fe, NM
Click here to add this to my saved trials
Motivational Enhancement for Spanish Speaking Individuals - 1
Motivational Enhancement for Spanish Speaking Individuals
Status: Enrolling
Updated:  1/11/2017
Narco Freedom (Bridge Plaza)
mi
from
Long Island City, NY
Motivational Enhancement for Spanish Speaking Individuals - 1
Motivational Enhancement for Spanish Speaking Individuals
Status: Enrolling
Updated: 1/11/2017
Narco Freedom (Bridge Plaza)
mi
from
Long Island City, NY
Click here to add this to my saved trials
Motivational Enhancement for Spanish Speaking Individuals - 1
Motivational Enhancement for Spanish Speaking Individuals
Status: Enrolling
Updated:  1/11/2017
Changepoint - Cedar Hills Blvd
mi
from
Portland, OR
Motivational Enhancement for Spanish Speaking Individuals - 1
Motivational Enhancement for Spanish Speaking Individuals
Status: Enrolling
Updated: 1/11/2017
Changepoint - Cedar Hills Blvd
mi
from
Portland, OR
Click here to add this to my saved trials
Motivational Enhancement for Spanish Speaking Individuals - 1
Motivational Enhancement for Spanish Speaking Individuals
Status: Enrolling
Updated:  1/11/2017
ChangePoint, Inc.
mi
from
Portland, OR
Motivational Enhancement for Spanish Speaking Individuals - 1
Motivational Enhancement for Spanish Speaking Individuals
Status: Enrolling
Updated: 1/11/2017
ChangePoint, Inc.
mi
from
Portland, OR
Click here to add this to my saved trials
Baclofen for the Treatment of Cocaine Dependence - 1
Multi-Center Trial of Baclofen for the Treatment of Cocaine Dependence
Status: Enrolling
Updated:  1/11/2017
San Francisco General Hosptial
mi
from
San Francisco, CA
Baclofen for the Treatment of Cocaine Dependence - 1
Multi-Center Trial of Baclofen for the Treatment of Cocaine Dependence
Status: Enrolling
Updated: 1/11/2017
San Francisco General Hosptial
mi
from
San Francisco, CA
Click here to add this to my saved trials
Baclofen for the Treatment of Cocaine Dependence - 1
Multi-Center Trial of Baclofen for the Treatment of Cocaine Dependence
Status: Enrolling
Updated:  1/11/2017
Torrance Site
mi
from
Torrance, CA
Baclofen for the Treatment of Cocaine Dependence - 1
Multi-Center Trial of Baclofen for the Treatment of Cocaine Dependence
Status: Enrolling
Updated: 1/11/2017
Torrance Site
mi
from
Torrance, CA
Click here to add this to my saved trials
Baclofen for the Treatment of Cocaine Dependence - 1
Multi-Center Trial of Baclofen for the Treatment of Cocaine Dependence
Status: Enrolling
Updated:  1/11/2017
Denver VA Medical Center
mi
from
Denver, CO
Baclofen for the Treatment of Cocaine Dependence - 1
Multi-Center Trial of Baclofen for the Treatment of Cocaine Dependence
Status: Enrolling
Updated: 1/11/2017
Denver VA Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Baclofen for the Treatment of Cocaine Dependence - 1
Multi-Center Trial of Baclofen for the Treatment of Cocaine Dependence
Status: Enrolling
Updated:  1/11/2017
VA Maryland Healthcare System
mi
from
Baltimore, MD
Baclofen for the Treatment of Cocaine Dependence - 1
Multi-Center Trial of Baclofen for the Treatment of Cocaine Dependence
Status: Enrolling
Updated: 1/11/2017
VA Maryland Healthcare System
mi
from
Baltimore, MD
Click here to add this to my saved trials
Baclofen for the Treatment of Cocaine Dependence - 1
Multi-Center Trial of Baclofen for the Treatment of Cocaine Dependence
Status: Enrolling
Updated:  1/11/2017
U of Penn School of Medicine
mi
from
Philadelphia, PA
Baclofen for the Treatment of Cocaine Dependence - 1
Multi-Center Trial of Baclofen for the Treatment of Cocaine Dependence
Status: Enrolling
Updated: 1/11/2017
U of Penn School of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Baclofen for the Treatment of Cocaine Dependence - 1
Multi-Center Trial of Baclofen for the Treatment of Cocaine Dependence
Status: Enrolling
Updated:  1/11/2017
South TX VA Health Care System
mi
from
San Antonio, TX
Baclofen for the Treatment of Cocaine Dependence - 1
Multi-Center Trial of Baclofen for the Treatment of Cocaine Dependence
Status: Enrolling
Updated: 1/11/2017
South TX VA Health Care System
mi
from
San Antonio, TX
Click here to add this to my saved trials